Pooncharas Tipgunlakant

• ● Led oncology market development initiatives across tertiary hospitals, increasing treatment adoption through evidence-based HCP engagement.

• ● Contributed to market expansion and increased treatment uptake within assigned regions through optimized pricing strategy, hospital contracting, and structured key account management.

• ● Achieved high private-sector adoption for a flagship subcutaneous oncology therapy through value-based positioning and multi-stakeholder alignment.

• ● Built and scaled strategic partnerships with top-tier hospital groups and oncology networks, accelerating market penetration.

• ● Collaborated cross-functionally with marketing, medical affairs, market access, and operations to address access barriers while ensuring compliance and scientific consistency.

• ● Initiated service-based and decentralized care business models, strengthening competitive differentiation and long-term growth.

Selected

◦ ● Ophthalmology Commercial Rotation (2025): Drove significant, accelerated sales growth and successfully implemented a patient access program in a focused hospital account within four months

◦ ● Digital Health & AI Market Research Global contributor to AI-driven diagnostic innovation, Facilitated market research and customer segmentation across APAC & EMEA.

◦ ● Global Work Packages Analyzed cross-affiliate gaps and supported deployment of standardized global procedures.

• ● Owned the commercial strategy and business development for genomic profiling services in oncology.

• ● Supporting the implementation of precision medicine approaches (companion diagnostics) in everyday clinical practice

• ● Expanded test adoption by educating oncologists on clinical and economic value, while building strong partnerships with laboratory providers.

• ● Expanding streamlining service implementation across multiple hospital networks.